Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Topic Home
bullet Mycotic Diseases
bullet Current Research
bullet Training / Research
Opportunities
  bullet Reference Services
  bullet Related Links
  bullet What's New
  bullet Goals
  bullet Publications
  bullet Staff
Contact Info

1600 Clifton Road NE, MS-G11
Atlanta, GA 30033
Phone: + 1-800-311-3435

 
Division of Bacterial and Mycotic Diseases, Mycotic Diseases Branch

Publications

2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998

 2005

Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob Agents Chemother 2005; 49: 783-7.

Brandt ME, Gaunt D, Iqbal N, McClinton S, Hambleton S, Sigler L. False-positive Histoplasma capsulatum Gen-Probe chemiluminescent test result caused by a Chrysosporium species. J Clin Microbiol 2005; 43: 1456-8.

Kainer MA, Keshavarz H, Jensen BJ, Arduino MJ, Brandt ME, Padhye AA, Jarvis WR, Archibald LK. Saline-filled breast implant contamination with Curvularia spp. among women who underwent cosmetic breast augmentation. J Infect Dis 2005; 192:170-177.

Cano MV, Perz JF, Craig AS, Liu M, Lyon GM, Brandt ME, Lott TJ, Lasker BA, Barrett FF, McNeil MM, Schaffner W, Hajjeh RA. Candidemia in pediatric outpatients receiving home total parenteral nutrition. Med Mycol 2005; 43: 219-225.

Chowdhary A, Randhawa HS, Sharma S, Brandt ME, Kumar S. Malassezia furfur in a case of onychomycosis: colonizer or etiologic agent? Med Mycol 2005; 43: 87-90.

Ellepola AN, Morrison CJ, Laboratory diagnosis of invasive candidiasis. J Microbiol 2005; 43(S): 65-84.

Fridkin S. The changing face of fungal infections in healthcare settings. Clin Infect Dis 2005; 41: 1455-60.

Fridkin S. Candidemia is costly-plain and simple. Clin Infect Dis 2005; 41: 1240-41.

Hinrikson HP, Hurst SF, de Aguirre L, Morrison CJ, Molecular methods for the identification of Aspergillus species. Med Mycol 2005; 43 S1: S129-137.

Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ, Assessment of ribosomal large subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of me dically important Aspergillus species. J Clin Microbiol 2005; 43: 2092-103.

Huhn GD, Austin C, Carr M, Heyer D, Boudreau P, Gilbert G, Eimen T, Lindsley MD, Cali S, Conover CS, Dworkin MS. Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk. Environmental Health Perspectives 2005; 113: 585-9.

Lott TJ, Fundyga RE, Kuykendall RJ, Arnold J. The human commensal yeast, Candida albicans, has an ancient origin. Fungal Genet Biol 2005; 42: 444-51.

McCaig LF, McNeil MM. Trends in prescribing for vulvovaginal candidiasis. Pharmacoepidemiol Drug Saf 2005; 14: 113-20.

Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie S, Wilcox S, Harrison LH, Seaburg E, Hajjeh RA, Teutsch SM. Excess mortality, hospital stay and cost due to candidemia: a case-control study using data from a population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26:540-547.

Morgan J, Wannemuehler K, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW, Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43S1: S49-58.

Morgan J, Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep. 2005; 7: 429-39.

Cuenca-Estrella M, Rodriguez D, Almirante B, Morgan J, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Salvado M, Warnock DW, Pahissa A, Rodríguez-Tudela JL. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance program me, Barcelona, Spain, 2002-2003. J Antimicrob Chemother 2005; 55: 194-9.

Mostert L, Groenwald JZ, Summerbell RC, Robert V, Sutton DA, Padhye AA, Crous PW. Species of Phaeoacremonium associated with infections in humans and environmental reservoirs in infected woody plants. J Clin Microbiol 2005; 43: 1752-67.

Park BJ, Sigel K, Vaz V, Komatsu K, McRill C, Phelan M, Colman T, Comrie AC, Warnock DW, Galgiani JN, Hajjeh RA, An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 2005; 191: 1981-7.

Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-35.

Shetty SS, Harrison LH, Hajjeh RA, Taylor TH, Mirza SA, Bustamante Schmidt A, Thomson Sanza L, Schutt KA, Fridkin SK. Evaluating risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J. 2005; 24:601-604.

Return to Top

 2004

da Silva Ferreira ME, Capellaro JL, dos Reis Marques E, Malavazi I, Perlin D, Park S, Anderson JB, Colombo AL, Arthington-Skaggs BA, Goldman MHS, Goldman GH. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple me chanisms of resistance. Antimicrob Agents Chemother 2004; 48: 4405-13.

Brandt ME, Kauffman CA, Pappas PG, Iqbal N, Arthington-Skaggs BA, Lee-Yang W, Smith TH. Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient. J Clin Microbiol 2004; 42: 3363-5.

Coignard C, Hurst SF, Benjamin LE, Brandt ME, Warnock DW, Morrison CJ, Resolution of discrepant results for Candida species identification by using DNA probes. J Clin Microbiol 2004; 42: 858-61.

Clark TA, Slavinski SA, Morgan J, Lott TJ, Arthington-Skaggs BA, Brandt ME, Webb RM, Currier M, Flowers RH, Fridkin SK, Hajjeh RA. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 2004; 42: 4468-72.

Kuhn DM, Mukherjee PK, Clark TA, Pujol C, Chandra J, Hajjeh RA, Warnock DW, Soll DR, Ghannoum MA. Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis 2004; 10: 1074-81.

Proia LA, Hayden MK, Kammeyer PL, Ortiz J, Sutton DA, Clark TA, Schroers HJ, Summerbell RC. Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis 2004; 39: 373-9.

de Aguirre L, Hurst SF, Choi JS, Shin JH, Hinrikson HP, Morrison CJ, Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol 2004; 42: 3495-3504.

Frade JP, Warnock DW, Arthington-Skaggs BA, Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J Clin Microbiol 2004; 42: 2085-93.

Fundyga RE, Kuykendall RJ, Lee-Yang W, Lott TJ, Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis. Infect Genet Evol 2004; 4: 37 -43.

Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Thomson Sanza L, Huie S, Yeo SF, Brandt ME, Warnock DW. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519-27.

Petersen LR, Marshall SL, Barton C, Hajjeh RA, Lindsley MD, Warnock DW, Panackal AA, Shaffer JB, Haddad MB, Fisher FS, Dennis DT, Morgan J. Coccidioidomycosis among workers at an archeological site, Northeastern Utah. Emerg Infect Dis 2004; 10: 637-42.

Hajjeh RA, Warnock DW. Travel-associated fungal infections. In: Scheld WM, Murray BE, Hughes JM, eds. Emerging Infections 6. Washington, DC: ASM Press, 2004: 133-142.

Lasker BA, Ran Y. Analysis of polymorphic microsatellite markers for typing Penicillium marneffei isolates. J Clin Microbiol 2004; 42: 1483-90.

Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA, Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 2004; 53: 217-24.

Odds FC, Motyl M, Andrade R, Bille J, Canton E, Cuenca-Estrella M, Davidson A, Durusssel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdiere M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Peman J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela JL, Schell W, Shields C, Sutton DA, Verweij PE, Warnock DW, Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol 2004; 42: 3475-82.

Lyon GM, Bravo AV, Espino A, Lindsley MD, Gutierrez RE, Rodriguez I, Corella A, Carrillo F, McNeil MM, Warnock DW, Hajjeh RA. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. Am J Trop Med Hyg 2004; 70: 438-42.

Ghannoum MA,Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rinaldi MG, Lee-Yang W, Warnock DW, Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol 2004; 42: 2977-9.

Chamany S, Mirza SA, Fleming JW, Howell JF, Lenhart SW, Mortimer VD, Phelan MA, Lindsley MD, Iqbal ND, Wheat LJ, Brandt ME, Warnock DW, Hajjeh RA. A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr Infect Dis J 2004; 23: 904-14.

Chakrabarti A, Marak RS, Sakhuja V, Gupta S, Padhye AA, Subcutaneous phaeohyphomycotic infection in a renal transplant recipient caused by Exophiala jeansel me i: a case report and review of the literature. J Mycol Med 2004; 14: 206-9.

Mackie JT, Padhye AA, Sutherland RJ, Lamb WA, Davis S. Granulomatous lymphadenitis and splenitis associated with Monocillium indicum infection in a dog. J Vet Diagn Invest 2004; 16: 248-50.

O'Donnell K, Sutton DA, Rinaldi MG, Magnon KC, Cox PA, Revankar SG, Sanche S, Geiser DM, Juba JH, van Burik JAH, Padhye AA, Anaissie EJ, Francesconi A, Walsh TJ, Robinson JS. Genetic diversity of human pathogenic me mbers of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol 2004; 42: 5109-20.

Padhye AA, Karpati A, Rosenthal SA, Punithalingam E. Subcutaneous phaeohyphomycotic abscess caused by Pleurophomopsis lignicola, Med Mycol 2004; 42: 129-34.

Verghese S, Maria CF, Mullaseri AS, Asha M, Padmaja P, Padhye AA, Aspergillus endocarditis presenting as femoral artery embolism. Mycoses 2004; 47: 252-6.

Return to Top

 2003

Amornkul PN, Hu DJ, Tansuphasawadikul S, Lee S, Eampokalap B, Likanonsakul S, Nelson R, Young NL, Hajjeh RA, Limpakarnjanarat K, Mastro TD. Human immunodeficiency virus type 1 subtype and other factors associated with extrapulmonary cryptococcosis among patients in Thailand with AIDS. AIDS Res Hum Retroviruses 2003; 19: 85-90.

Brandt ME, Benjamin LE, Steinkraus GE. Pseudo-outbreak of Candida versatilitis in a microbiology laboratory. Diagn Microbiol Infect Dis 2003; 46: 73-5.

Brandt ME,Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003; 15 suppl. 2: 36-47.

Brandt ME, Warnock DW. Laboratory aspects of medical mycology. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York: Oxford University Press, 2003: 3-22.

Cano MV, Ponce-de-Leon GF, Tippen S, Lindsley MD, Warwick M, Hajjeh RA. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 2003; 131: 907-914.

Ellepola ANB, Hurst SF, Elie CM, Morrison CJ. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods. Oral Microbiol Immunol 2003; 18: 379-88.

Ghannoum M, Isham N, Hajjeh RA, Cano M, Al-Hasawi F, Yearick D, Warner J, Long L, Jessup C, Elewski B. Tinea capitis in Cleveland: survey of elementary school students. J Am Acad Dermatol 2003; 48: 189-93.

Hajjeh RA, Warnock DW. Introduction to the epidemiology of fungal diseases. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York: Oxford University Press, 2003: 23-30.

Hajjeh RA,Warnock DW. Surveillance des mycoses invasives. Ann Inst Pasteur 2003; 17: 61-73.

Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA, Warnock DW. Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. J Clin Microbiol 2003; 41: 1316-21.

Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME, Douglas S, Shutt K, Warnock DW, Hajjeh RA. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis 2003; 36: 34-9.

Makarova NU, Pokrowsky VV, Kravchenko AV, Serebrovskaya LV, James MJ, McNeil MM, Lasker BA, Warnock DW, Reiss E. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility. J Clin Microbiol 2003; 41: 1833-7.

Matsushita A, Jilong L, Hiruma M, Kobayashi M, Matsumoto T, Ogawa H, Padhye AA. Subcutaneous phaeohyphomycosis caused by Veronaea botryosa in the People’s Republic of China. J Clin Microbiol 2003; 41: 2219-22.

McGinnis MR, Padhye AA. Fungi causing eumycotic mycetoma. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH, eds. Ma nual of Clinical Microbiology, 8 th ed. Washington DC: ASM Press, 2003: 1848-56.

Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, Ponce-de-Leon G, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in two large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36:789-94.

Morgan J, Cano MV, Feikin DR, Phelan M, Monroy OV, Morales PK, Carpenter J, Weltman A, Spitzer PG, Liu HH, Mirza SA, Bronstein DE, Morgan DJ, Kirkman LA, Brandt ME, Iqbal NE, Lindsley MD, Warnock DW, Hajjeh RA. A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001. Am J Trop Med Hyg 2003; 69: 663-9.

Morrison CJ, Hurst SF, Reiss E. C ompetitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin Diagn Lab Immunol 2003; 10: 835-48.

Padhye AA, Verghese S, Ravichandran P, Balamurugan G, Hall L, Padmaja P, Fernandez MC. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol 2003; 41: 479-82.

Panackal AA, Dahlman A, Keil KT, Peterson CL, Mascola L, Mirza S, Phelan M, Lasker BA, Brandt ME, Carpenter J, Bell M, Warnock DW, Hajjeh RA, Morgan J. Outbreak of invasive aspergillosis among renal transplant recipients. Transplantation 2003; 75: 1050-3.

Richardson MD, Warnock DW. Fungal Infection: Diagnosis and Management, 3 rd ed. Oxford: Blackwell Publishing, 2003.

Sugiura Y, Sugita-Konishi Y, Kumagai S, Reiss E. Experimental murine hyalohyphomycosis with soil-derived isolates of Fusarium solani. Med Mycol 2003; 41: 241-7.

Warnock DW, Antifungal agents. In: Finch RG, Greenwood D, Norrby SR, Whitley RJ, eds. Antibiotic and Chemotherapy, 8 th ed. London: Churchill Livingstone, 2003: 414-26.

Warnock DW, Superficial fungal infections. In: Cohen J, Powderly WG, eds. Infectious Diseases, 2 nd ed. London: Mosby, 2003: 173-80.

Weinberg M, Weeks J, Lance-Parker S, Traeger M, Wiersma S, Phan Q, Dennison D, MacDonald P, Lindsley MD, Guarner J, Connolly P, Cetron M, Hajjeh RA. Severe histoplasmosis in travelers to Nicaragua. Emerg Infect Dis 2003; 9: 1322-5.

Return to Top

 2002


Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock DW, for the Candidemia Active Surveillance Group. Comparison of visual and spectrophotometric methods of broth microdilution MIC endpoint determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 2002; 46: 2477-81.

Barnes RA, Warnock DW, eds. Fungal Infection in the Intensive Care Unit. Norwell: Kluwer Academic Publishers, 2002.

Chakrabarti A, Marhawa RK, Mondal R, Trehani A, Gupta S, Raman Rao DSV, Sethi S, Padhye AA. Generalized lymphadenopathy caused by Trichosporon asahii in a patient with Job’s syndrome. Med Mycol 2002; 40: 83-6.

Clark TA, Hajjeh RA, Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569-74.

Cuenca-Estrella M, Lee-Yang W, Ciblak M, Arthington-Skaggs BA, Mellado E, Warnock DW, Rodriguez-Tudela JL. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob Agents Chemother 2002; 46: 3644-7.

Fundyga RE, Lott TJ, Arnold J. Population structure of Candida albicans, a member of the human flora, as determined by microsatellite loci. Infect Genet Evol 2002; 2: 57-68.

Hajjeh RA, Lyon GM, Epidemiology of Candida infections in the intensive care unit. In: Barnes RA, Warnock DW, eds. Fungal Infection in the Intensive Care Unit. Norwell: Kluwer Academic Publishers, 2002: 1-12.

Hajjeh RA, Warnock DW, Aspergillus species. In: Long SS, Pickering L, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2 nd ed. Orlando: Harcourt, 2002: 1213-20.

Hajjeh RA, Warnock DW, Zygomycetes (mucormycosis). In: Long SS, Pickering L, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2 nd ed. Orlando: Harcourt, 2002: 1222-5.

Hajjeh RA, Warnock DW, Malassezia species. In: Long SS, Pickering L, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2 nd ed. Orlando: Harcourt, 2002: 1225-7.

Hajjeh RA, Warnock DW, Sporothrix schenckii. In: Long SS, Pickering L, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2 nd ed. Orlando: Harcourt, 2002: 1227-9.

Hajjeh RA, Warnock DW, Cryptococcus neoformans. In: Long SS, Pickering L, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2 nd ed. Orlando: Harcourt, 2002: 1229-33.

Howard DH, Weitzman I, Padhye AA. Onygenales: Arthrodermataceae. In:Howard DH, ed. Pathogenic Fungi in Humans and Animals, 2 nd ed. New York: Marcel Dekker, Inc., 2002: 141-94.

Jia N, Arthington-Skaggs BA, Lee W, Pierson CA, Lees ND, Eckstein J, Barbuch R, Bard M. Characterization of the Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 2002; 46: 947-57.

Karimi K, Wheat LJ, Connolly P, Cloud G, Hajjeh RA, Wheat E, Alves K, da Silva Lacaz C, Keath E. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186: 1655-60.

Lasker BA, Evaluation of performance of four genotypic methods for studying the genetic epidemiology of Aspergillus fumigatus isolates. J Clin Microbiol 2002; 40: 2886-92.

Miller WG, Padhye AA, van Bonn W, Jensen E, Brandt ME, Ridgway SH. Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii. J Clin Microbiol 2002; 40: 721-4.

Morrison CJ. Laboratory diagnosis of fungal infection in the intensive care unit. In: Barnes RA, Warnock DW, eds. Fungal Infection in the Intensive Care Unit. Norwell: Kluwer Academic Publishers, 2002: 55-104.

Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002; 35: 1088-95.

Panackal AA, M’ikanatha NM, Tsui F-C, McMahon J, Wagner MW, Dixon BW, Zubieta J, Phelan M, Mirza S, Morgan J, Jernigan D, Pasculle AW, Rankin JT, Hajjeh RA, Harrison LH. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis 2002; 8: 685-91.

Pegues DA, Lasker BA, McNeil MM, Hamm PM, Lundal JL, Kubak BM. Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis 2002; 34: 412-6.

Reiss E, Kaufman L, Kovacs JA, Lindsley MD. Clinical immunomycology. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Laboratory Immunology, 6 th ed. Washington, DC: ASM Press, 2002: 559-83.

Rimland D, Navin TR, Lennox JL, Jernigan JA, Kaplan J, Erdman D, Morrison CJ, Wahlquist SP. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002; 16: 85-95.

Rosner ER, Reiss E, Warren NG, Shadomy HJ, Lipman HB. Evaluation of the status of laboratory practices and the need for continuing education in medical mycology. Am J Clin Pathol 2002; 118: 278-86.

Summerbell RC, Weitzman I, Padhye AA. The Trichophyton mentagrophytes complex: biological species and mating type prevalences of North American isolates, and a review of the worldwide distribution and host associations of species and mating types. Studies in Mycology 2002; 47: 75-85.

Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, and the National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-30.

Verghese S, Arjundas D, Krishnakumar KC, Padmaja P, Elizabeth D, Padhye AA, Warnock DW. Coccidioidomycosis in India: report of a second imported case. Med Mycol 2002; 40: 307-9.

Xu, J, Luo G, Vilgalys RJ, Brandt ME, Mitchell TG. Multiple origins of hybrid strains of Cryptococcus neoformans with serotype AD. Microbiology 2002; 148: 203-12.

Return to Top

 2001

Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, for the Cryptococcal Disease Active Surveillance Group. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 2001; 45: 3065-9.

Burwen DR, Lasker BA, Rao N, Durry E, Padhye AA, Jarvis WR. Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol 2001; 22: 45-8.

Cano MVC, Hajjeh RA, The epidemiology of histoplasmosis: a review. Semin Respir Infect 2001; 16: 109-18.

Chakrabarti A, Singh K, Narang A, Singhi S, Batra R, Rao KLN, Ray P, Gopalan S, Das S, Gupta V, Gupta AK, Bose SM, McNeil MM. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in northern India. J Clin Microbiol 2001; 39: 1702-6.

Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, Phelan MA, Cloud G, Holloway M, Kauffman CA, Wheat LJ, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001; 32: 1215-20.

Hajjeh RA, Warnock DW, Counterpoint: Invasive aspergillosis and the environment: rethinking our approach to prevention. Clin Infect Dis 2001; 33: 1549-52.

Hannah EL, Bailey AM, Hajjeh RA, Gershman K, Lindsley MD, Hoffman RE. Public health response to 2 clinical cases of blastomycosis in Colorado residents. Clin Infect Dis (electronic edition) 2001; 32: e151-3.

Hien TV, Loc PP, Hoa NTT, Duong NM, Quang VM, McNeil MM, Dung NT, Ashford DA. First cases of disseminated penicilliosis marneffei infection among patients with acquired immunodeficiency syndrome in Vietnam. Clin Infect Dis (electronic edition) 2001; 32: e78-80.

Lasker BA, Elie CM, Lott TJ, Espinel-Ingroff A, Gallagher L, Kuykendall RJ, Kellum ME, Pruitt WR, Warnock DW, Rimland D, McNeil MM, Reiss E. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits. Med Mycol 2001; 39: 341-52.

Lindsley MD, Hurst SF, Iqbal NJ, Morrison CJ, Rapid identification of dimorphic and yeast-like fungal pathogens using specific DNA probes. J Clin Microbiol 2001; 39: 3505-11.

Lott TJ, Effat MM, Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology 2001; 147: 1687-92.

Lyon GM, Smilack JD, Komatsu KK, Pasha TM, Leighton JA,Guarner J, Colby TV, Lindsley MD, Phelan M, Warnock DW, Hajjeh RA. Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiologic characteristics and review of the literature. Clin Infect Dis 2001; 32: 1448-55.

McGinnis MR, Nordoff N, Li RK, Pasarell L, Warnock DW. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol 2001; 39: 369-71.

McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33: 641-7.

Miller LG, Hajjeh RA, Edwards JE. Estimating the cost of nosocomial candidemia in the United States. Clin Infect Dis 2001; 32: 1110.

Morrison CJ, Lindsley MD, Serological approaches to the diagnosis of invasive fungal infections. In: Calderone RA, Cihlar RL, eds. Fungal Pathogenesis: Principles and Clinical Applications. New York: Marcel Dekker Inc., 2001: 667-716.

Muniz MM, Pizzini CV, Peralta JM, Reiss E, Zancope-Oliveira RM. Genetic diversity of Histoplasma capsulatum strains isolated from soil, animals, and clinical specimens in Rio de Janeiro State, Brazil, by a PCR-based random amplified polymorphic DNA assay. J Clin Microbiol 2001; 39: 4487-94.

Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW, for the National Committee on Clinical Laboratory Standards Antifungal Susceptibility Testing Subcommittee. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001; 14: 643-58.

Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, Vugia D, Reingold A, Talbot R, Plikaytis BD, Perkins BA, Hajjeh RA. Risk factors for severe pulmonary and disseminated coccidioidomycosis, Kern County, California, 1995-1996. Clin Infect Dis 2001; 32: 708-15.

Schinsky MF, Padhye AA, McDonnell M, Brown JM, Stern L. Pulmonary zygomycosis in an HIV-positive patient with end stage renal disease on continuous ambulatory peritoneal dialysis. J Mycol Med 2001; 11: 161-5.

Warnock DW, Hajjeh RA, Lasker BA, Epidemiology and prevention of invasive aspergillosis. Curr Infect Dis Rep 2001; 3: 507-16.

Return to Top

 2000

Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ. Comparative evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. J Clin Microbiol 2000; 38: 2254-60.

Arthington-Skaggs BA, Warnock DW, Morrison CJ, Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother 2000; 44: 2081-5.

Brandt ME, Harrison LH, Pass M, Sofair A, Huie S, Li RK, Morrison CJ, Warnock DW, Hajjeh RA. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000; 6: 46-9.

Burns RA, Roy JS, Woods C, Padhye AA, Warnock DW. Report of the first human case of lobomycosis in the United States. J Clin Microbiol 2000; 38: 1283-5.

Cairns L, Blythe D, Kao A, Pappagianis D, Kaufman L, Kobayashi J, Hajjeh RA. Outbreak of coccidioidomycosis in Washington State residents returning from Mexico. Clin Infect Dis 2000; 30: 61-4.

Ellis D, Marriott D, Hajjeh RA, Warnock DW, Meyer W, Barton R. Epidemiology: surveillance of fungal infections Med Mycol 2000; 38 (suppl. 1):173-82.

Espinel-Ingroff A, Warnock DW, Vazquez JA, Arthington-Skaggs BA. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med Mycol 2000; 38 (suppl. 1): 293-304.

Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, Rebell G, Lesher J, Gerlach B, Ponce-de-Leon GF, Ghannoum A, Warner J, Isham N, Elewski B. A large scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641-8.

Hemashettar BM, Siddaramappa B, Padhye AA, Sigler L, Chandler FW. White grain mycetoma caused by a Cylindrocarpon sp. in India. J Clin Microbiol 2000; 38: 4288-91.

Hurst SF, Reyes GH, McLaughlin DW, Reiss E, Morrison CJ, Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis. Clin Diagn Lab Immunol 2000; 7: 477-85.

James MJ, Lasker BA, McNeil MM, Shelton M, Warnock DW, Reiss E. Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol 2000; 38: 3612-8.

Kauffman C, Hajjeh RA, Chapman SW, for the Mycoses Study Group. Practice guid elines for the management of patients with sporotrichosis. Clin Infect Dis 2000; 30: 684-7.

Leake JAD, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NM, Perkins BA, Hajjeh RA. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 2000; 181: 1435-40.

Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000; 44: 1734-6.

Li RK, Elie CM, Clayton GE, Ciblak MA. Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M27-A) for antifungal drug MIC determination. J Clin Microbiol 2000; 38: 2334-8.

Mussa AY, Randhawa HS, Khan ZU, Padhye AA, Ajello L. Occurrence and significance of Trichophyton mentagrophytes var. mentagrophytes on the bark of Eucalyptus camaldulensis in India. J Mycol Med 2000; 10: 136-9.

Reiss E, Obayashi T, Orle K, Yoshida M, Zancope-Oliveira RM. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38 (suppl. 1): 147-59.

Warnock DW, Mycotic agents of human disease. In: Fleming DO, Hunt DL, eds. Biological Safety: Principles and Practices. Washington, DC: ASM Press, 2000: 111-20.

Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh RA. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30: 877-81.

Woods CW, McRill C, Plikaytis BD, Rosenstein NE, Mosley D, Boyd D, England B, Perkins BA, Ampel NM, Hajjeh RA. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 2000; 181: 1428-34.

Wu T, Wright K, Hurst SF, Morrison CJ. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in sub-inhibitory concentrations of fluconazole. Antimicrob Agents Chemother 2000; 44: 1200-8.

Zancope-Oliveira RM, James MJ, Derossi AP, Sampaio JLM, Muniz MM, Li RK, Nascimento ASA, Peralta JM, Reiss E. Strain characterization of Candida parapsilosis fungemia by molecular typing methods. Eur J Clin Microbiol Infect Dis 2000; 19: 514-20.

Return to Top

 1999

Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 1999; 37: 3332-7.

Ashford DA, Hajjeh RA, Kelley MF, Kaufman L, Hutwagner L, McNeil MM. Outbreak of histoplasmosis among cavers attending the National Speleological Society annual Convention, Texas, 1994. Am J Trop Med Hyg 1999; 60: 899-903.

Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner L, Schuchat A, Brandt ME, Pinner RW, and the Cryptococcal Active Surveillance Group. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999; 179: 449-54.

Jones TF, Swinger GL, Craig AS, McNeil MM, Kaufman L, Schaffner W. Acute pulmonary histoplasmosis in bridge workers: a persistent problem. Am J Med 1999; 106: 480-2.

Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-70.

Lott TJ, Holloway BP, Logan DA, Fundyga R, Arnold J. Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology 1999; 145: 1137-43.

Louie L, Ng S, Hajjeh RA, Johnson R, Vugia D, Werner SB, Talbot R, Klitz W. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 1999; 5: 672-80.

McNeil MM, Lasker BA, Lott TJ, Jarvis WR. Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent. J Clin Microbiol 1999; 37: 1398-1403.

Padhye AA, Dunkel JD, Winn RM, Weber S, Ewing EP, de Hoog GS. Subcutaneous phaeohyphomycosis caused by an undescribed Cladophialophora species. Studies in Mycology 1999; 43: 172-5.

Padhye AA, McGinnis MR. Fungi causing eumycotic mycetoma. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7 th ed. Washington DC: ASM Press, 1999: 1318-26.

Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME, Hajjeh RA. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217-22.

Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 1999; 43: 169-71.

Pincus DH, Coleman DC, Pruitt WR, Padhye AA, Salkin IF, Geimer M, Bassel A, Sullivan DJ, Clarke M, Hearn V. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; 37: 3533-39.

Pizzini CV, Zancope-Oliveira RM,Reiss E, Hajjeh RA, Kaufman L, Peralta JM. Evaluation of a western blot test in an outbreak of acute pulmonary histoplasmosis. Clin Diagn Lab Immunol 1999; 6: 20-3.

Shin JH, Nolte FS, Holloway BP, Morrison CJ. Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol 1999; 37: 165-70.

Singh PN, Ranjana K, Singh YI, Singh KP, Sharma SS, Kulachandra M, Nabakumar Y, Chakrabarti A, Padhye AA, Kaufman L, Ajello L. Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: report of four autochthonous cases. J Clin Microbiol 1999; 37: 2699-702.

Sugiura Y, Barr JR, Barr DB, Brock JW, Elie CM, Ueno Y, Patterson DG, Potter ME, Reiss E. Physiological characteristics and mycotoxins of human clinical isolates of Fusarium species. Mycol Res 1999; 103: 1462-8.

Warnock DW, Superficial fungal infections. In: Armstrong D, Cohen J, eds. Infectious Diseases. London: Mosby, 1999: 2.6.1-6.

Warnock DW, Arthington-Skaggs BA, Li RK, Antifungal drug susceptibility testing and resistance in aspergillus. Drug Resistance Updates 1999; 2: 326-34.

Zancope-Oliveira RM, Reiss E, Lott TJ, Mayer LW, Deepe GS. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun 1999; 67: 1947-53.

Return to Top

 1998

Ampel NM, Mosley DG, England B, Vertz PD, Komatsu K, Hajjeh RA. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 1998; 27: 1528-30.

Borazjani RN, Lott TJ, Ahearn DG. Comparison of 5.8S and ITS2 rDNA RFLP patterns of Acremonium obclavatum, A. kiliense, and A. strictum from diverse sources. Curr Microbiol 1998; 36: 70-4.

Brandt ME, Padhye AA, Mayer LW, Holloway BP. Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus. J Clin Microbiol 1998; 36: 2057-62.

Chandler FW, McNeil MM, Kaufman L. Emerging fungal infections: histoplasmosis, phaeohyphomycosis and sporotrichosis. In: Nelson AM, Horsburgh CR, eds. Pathology of Emerging Infections 2. Washington DC: ASM Press, 1998:

Chang HJ, Miller HL, Watkins N, Arduino MJ, Ashford DA, Midgley G, Aguero SM, Pinto-Powell R, Von Reyn CF, Edwards W, McNeil MM, Jarvis WR. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med 1998; 338: 706-11.

Elie CM, Lott TJ, Reiss E, Morrison CJ, Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol 1998; 36: 3260-5.

Kaufman L, Valero G, Padhye AA. Misleading manifestations of Coccidioides immitis in vivo. J Clin Microbiol 1998; 36: 3721-3.

Lasker BA, Smith GW, Kobayashi GS, Whitney AM, Mayer LW. Characterization of a single group 1 intron in the 18S rRNA gene of the pathogenic fungus Histoplasma capsulatum. Med Mycol 1998; 36: 205-12.

Lott TJ, Burns BM, Zancope-Oliveira R, Elie CM, Reiss E. Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida. Curr Microbiol 1998; 36: 63-9.

Padhye AA, Bennett JE, McGinnis MR, Sigler L, Fliss A, Salkin IF. Biosafety considerations in handling medically important fungi. Med Mycol 1998; 36 (suppl. 1): 258-65.

Padhye AA, Davis MS, Baer D, Reddick A, Sinha KK, Ott J. Phaeohyphomycosis caused by Phaeoacremonium inflatipes. J Clin Microbiol 1998; 36: 2763-5.

Padhye AA, Weitzman I. The dermatophytes. In: Collier L, Balows A, Sussman M, eds. Topley and Wilson’s Microbiology and Microbial Infections, 9 th ed. Vol 4 Medical Mycology. New York: Oxford University Press, 1998: 215-36.

Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME, Hajjeh RA. In vitro susceptibilities of candida bloodstream isolates to the new triazole antifungals BMS-207147, SCH 56592, and voriconazole. Antimicrob Agents Chemother 1998; 42: 3242-4.

Reef SE, Lasker BA, Butcher DS, McNeil MM, Pruitt R, Keyserling H, Jarvis WR. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: a prospective study. J Clin Microbiol 1998; 36: 1255-9.

Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138-47.

Reiss E, Tanaka K, Bruker G, Chazalet V, Coleman D, Debeaupuis JP, Hanazawa R, Latge JP, Lortholary J, Makimura K, Morrison CJ, Murayama SY, Naoe S, Paris S, Sarfati J, Shibuya K, Sullivan D, Uchida K, Yamaguchi H. Molecular diagnosis and epidemiology of fungal infections. Med Mycol 1998; 36 (suppl. 1): 249-57.

Ricci RM, Evans JS, Meffert JJ, Kaufman L, Sadkowski LC. Primary cutaneous Aspergillus ustus infection: second reported case. J Am Acad Dermatol 1998; 38: 797-8.

Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 1998; 36: 1467.

Shenep JL, English BK, Kaufman L, Pearson TA, Thompson JW, Kaufman RA, Frisch G, Rinaldi MG. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin Infect Dis 1998; 27: 1388-93.

Tendolkar UM, Kerkar P, Jerajani H, Gogate A, Padhye AA. Phaeohyphomycotic ulcer caused by Phialophora verrucosa: successful treatment with itraconazole. J Infect 1998; 36: 122-5.

Return to Top

 
 
Date: November 15, 2005
Content source: Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435